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Protease inhibitors modulate apoptosis in mesangial cells de-
rived from a mouse model of HIVAN.
Background. Oxidative stress as well as opiate addiction has
been shown to play a role in the development of complica-
tions associated with human immunodeficiency virus (HIV)
infection.
Methods. We studied the occurrence of apoptosis in mesan-
gial cells derived from control (NTrMC) mice and mice
transgenic for HIV-1 genes (HTrMC) under basal and
morphine-stimulated states (MSS). We evaluated the effect of
free radical scavengers and antioxidants on HTrMC apoptosis
and production of superoxide under basal and MSS. In addition,
we examined the effect of protease inhibitors (PI) on apoptosis
of NTrMCs/HTrMCs as well as morphine-induced superoxide
dismutase (SOD) and nicotinamide adenine dinucleotide phos-
phate (reduced form) (NADPH) oxidase activation.
Results. HTrMCs showed greater apoptosis when compared
with NTrMCs. Morphine triggered (P < 0.001) apoptosis of
both NTrMCs and HTrMCs. Both antioxidants and free rad-
ical scavengers inhibited apoptosis of NTrMCs and HTrMCs
under both basal and MSS. Morphine stimulated the produc-
tion of superoxide by NTrMCs as well as by HTrMCs. Never-
theless, HTrMCs produced a greater (P < 0.001) amount of su-
peroxide when compared with NTrMCs both under basal and
MSS. PIs such as saquinavir and Indinavir inhibited HTrMC
apoptosis in a dose-dependent manner. Saquinavir also pro-
tected HTrMCs against the proapoptotic effect of morphine.
Moreover, saquinavir inhibited the production of superoxide
by HTrMCs under both basal and MSS. Saquinavir also atten-
uated the morphine-induced expression of SOD and NADPH
oxidase (Gp91phox) by HTrMCs. Interestingly, hemin exacer-
bated morphine-triggered HTrMC apoptosis.
Conclusion. Oxidative stress seems to play a role in the ac-
celerated rate of HTrMC apoptosis both under basal and MSS.
Saquinavir may be inhibiting HTrMC apoptosis by mitigating
oxidative stress.
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Human immmodeficiency virus (HIV)-associated
nephropathy (HIVAN) is the commonest cause of pro-
gressive renal injury in adult male African Americans
with HIV infection [1]. HIVAN is also the leading cause
of end-stage renal disease (ESRD) in this subpopulation.
Opiate addiction has also been reported to be an impor-
tant risk factor for the development of HIVAN in this sub-
group [2, 3]. Morphine (an active metabolite of heroin)
has been found to have a bimodal effect on mesangial
cell growth; it stimulates mesangial cell proliferation at
lower concentrations and triggers mesangial cell apopto-
sis at higher concentrations [4]. Interestingly, in biopsy
and autopsy studies, mesangial cell hyperplasia is the
most common feature in patients with HIV infection [2,
5]. However, full-blown HIVAN is characterized by focal
glomerulosclerosis (FGS) and microcystic dilatation of
tubules. FGS is accompanied by an expanded mesangium
containing an abundance of matrix and a reduced number
of mesangial cells.
Apoptosis in glomerular cells has been shown to be an
important process for normalizing the hypercellularity of
injured glomeruli [6–8]. In the majority of instances its
physiologic process brings the glomeruli back to normal
cellularity; however, if it proceeds unregulated, it may
lead to a pathologic lesion. The later may happen either
as a result of an altered environment or persistent up reg-
ulation of cytokines such as transforming growth factor-b
(TGF-b) [9, 10]. Sugiyama et al [11] suggested that the
occurrence of glomerular cell apoptosis is an important
event in the progression of glomerulosclerosis. Glomeru-
lar cell apoptosis has been demonstrated in human
diseases and in animal experimental models of renal abla-
tion, diabetes, and hypertensive nephrosclerosis [11–13].
Recently, there has been a suggestion that highly active
antiretroviral therapy (HAART) prevents the progres-
sion of renal injury in patients with HIV infection [14,
15]. HAART is combination of nucleoside reverse tran-
scriptase inhibitors (NRTI) and protease inhibitors [16,
17]. Protease inhibitors (PI) have been shown to have
antiapoptotic effect [18]. However, in clinical practice,
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patients on HAART show a significant increase in CD4
T-cell counts before any significant change in the viral
load [19, 20]. These studies suggest that the PI-induced
antiapoptotic effect may not be related to its antiviral
properties. We asked whether PIs modulate mesangial
cell apoptosis in mesangial cells derived from control
mice and/or mice transgenic for HIV-1 genes. Mesangial
cells derived from mice transgenic for HIV-1 genes have
previously been reported to have an accelerated rate of
apoptosis [21].
Oxidative stress has been reported to play a role in the
pathogenesis of acquired immunodeficiency syndrome
(AIDS) (22–25). Oxidative stress has also been demon-
strated to be associated with apoptosis (22, 26–28). In
in vitro studies, addition of hydrogen peroxide to HIV-
infected cells increased apoptosis [27]. On the other hand,
antioxidants inhibited apoptosis [27]. In in vivo studies,
administration of an antioxidant to patients with HIV in-
fection decreased apoptosis of peripheral blood lympho-
cytes [23]. Morphine is known to exert oxidative stress
in various cells, including mesangial cells [29]. Recently,
morphine has also been shown to up regulate the expres-
sion of heme oxygenase (HO)-2 in brain cells [30]. In the
present study, we evaluated the role of oxidative stress in
morphine-induced mesangial cell apoptosis. Since PIs are
the mainstay of the treatment of HIV infection we eval-
uated the effect of PIs on mesangial cells derived from
control and mice transgenic for HIV-1 genes under basal
and morphine-stimulated states.
METHODS
Mesangial cell culture
Glomerular mesangial cells were cultured by isolating
glomeruli from male FVB/N mice (Jackson Laboratories,
Bar Harbor, ME, USA) and mice transgenic for HIV
genes (TG26, with the background of FVB/N mice, were
kindly provided by Professor Paul E. Klotman, M.D.,
Chairman, Department of Medicine, Mount Sinai Medi-
cal Center, New York, NY, USA) of the same age and gen-
der as the transgene mice. Morphologic, functional, and
synthetic properties of these cells were tested before their
use, as described previously [21]. Both NTrMCs (apopto-
sis in mesangial cells derived from nontransgenic FVB/N
mice) and HTrMCs (apoptosis in mesangial cells derived
from mice transgenic for HIV-1 genes) were grown in
RPMl 1640 medium (Gibco, Grand Island, NY, USA)
containing 10% fetal calf serum (FCS) (Atlanta Biolog-
icals, Atlanta, GA, USA), 50 U/mL penicillin, and 50
lg/mL of streptomycin (Cellgro, Herndon, VA, USA).
Both NTrMCs and HTrMCs were used in their third to
fifth passage.
Experimental agents
Morphine was obtained from the National Insti-
tute on Drug Abuse, Rockville, MD. Ascorbic acid,
diphenyleneiodonium chloride (DPI) and N-acetyl L-
cysteine (NAC), hemin, tin protoporphyrin, and sodium
nitroprusside were obtained from Sigma Chemical Co.
(St. Louis, MO, USA). Saquinavir and Indinavir were
obtained from Merck (Westpoint, PA, USA), and Roche
Laboratories (Nutley, NJ, USA), respectively. HIV-1 Tat
was used in a concentration of 1.0 ng/mL and was ob-
tained from NIH AIDS Research and Reference Reagent
Program (Rockville, MD, USA). Mouse monoclonal
nicotinamide adenine dinucleotide phosphate (reduced
form) (Gp91phox) antibody was obtained from BD Bio-
sciences Pharmingen (San Diego, CA, USA). Sheep
anti-manganese–superoxide dismutase (MnSOD) anti-
body was obtained from Calbiochem (San Diego, CA,
USA).
Apoptosis studies
Morphologic evaluation of mesangial cell apoptosis
was performed by staining cells with H-33342 (Molec-
ular Probes, Portland, OR, USA) and propidium iodide
(Sigma Chemical Co.). H-33342 stains the nuclei of live
cells and identifies apoptotic cells by increased fluores-
cence, whereas propidium iodide costains the necrotic
cells. Double staining by these two agents provides the
percentage of live, apoptotic, and necrotic cells under
control and experimental conditions [31].
To determine the occurrence of apoptosis, NTrMCs and
HTrMCs were grown to subconfluence in 24-well plates.
Subsequently, cells were washed twice with phosphate
buffered saline (PBS) and incubated in media (including
1% FCS) containing either vehicle or morphine (10−6
mol/L) for 24 hours. At the end of the incubation pe-
riod, H-33342 (1 lg/mL) was added for 7 minutes at 37◦C.
Subsequently, cells (without a wash) were placed on ice
and propidium iodide (final concentration, 1 lg/mL) was
added to each well. Cells were incubated with the dyes for
10 minutes on ice, protected from light, and then exam-
ined under ultraviolet light. Percentage of live, apoptotic,
and necrotic cells was recorded in eight random fields by
two observers unaware of the experimental conditions.
To confirm the occurrence of mesangial cell apoptosis,
both NTrMCs and HTrMCs treated under control and
experimental conditions were assayed by the terminal
deoxynucleotidyl transferase-mediated uridine triphosp-
phate nick end labeling (TUNEL) method (apoptosis
kit supplied by Roche Applied Science, Indianapolis, IN,
USA).
DNA fragmentation assay: Gel electrophoresis
This is a simple method that is specific for isolation
and confirmation of DNA fragments from apoptotic cells
[32]. Equal numbers (108 cells/Petri dish) of HTrMCs un-
der control and experimental conditions were trypsinized
and centrifuged at 1600g for 10 minutes at room tempera-
ture and the pellets were resuspended in DNA lysis buffer
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[1% NP-40 in 20 mmol/L ethylenediaminetetraacetic acid
(EDTA), 50 mmol/L Tris-HCl, pH 7.5, 10 lL per 106
cells]. After centrifugation, the supernatant was collected
and the extraction was repeated. Sodium dodecyl sulfate
(SDS) in a final concentration of 1% was added to the su-
pernatants before the samples were treated with RNAse
A (final concentration 5 lg/lL) at 56◦C. This was followed
by digestion with proteinase K (Promega, Madison WI,
USA) for 2 hours at 37◦C. After addition of 1/2 volume
10 mol/L ammonium acetate, the DNA was precipitated
with 21/2 volume ethanol, dried, and then dissolved in gel
loading buffer, and separated by electrophoresis in 1.6%
agarose gels.
Superoxide assay
Equal numbers of NTrMCs and HTrMCs were plated
in 100 mm Petri dishes and grown to subconfluence. The
cells were washed twice with normal saline and incubated
in serum-free media under control and experimental con-
ditions. Supernatants were collected at 0, 30, 45, 60, and
120 minutes into precooled microcentrifuge test tubes. A
superoxide assay was carried out subsequently. In brief,
50 lL of each supernatant was pipeted into a 96-well
plate, kept on ice, and mixed with 100 lL of cytochrome C
(160 lmol/L final concentration ICN; Biomedicals, Inc.,
Costa Mesa, CA, USA) diluted with Hanks balanced salt
solution (HBSS) (Gibco). Incubation was carried out at
37◦C for 45, 90, and 120 minutes and optical density (OD)
read at 550 nm. Results are expressed in arbitrary units
and experiments repeated four times, each in triplicate.
Hydrogen peroxide (H2O2) assay
Equal numbers of NTrMCs and HTrMCs were plated
in 100 mm Petri dishes and grown to subconfluence. The
cells were washed twice with normal saline and cells were
incubated in serum-free media under control and exper-
imental conditions. Supernatants were collected at 0, 30,
45, 60, and 120 minutes into precooled microcentrifuge
test tubes. A H2O2 assay was carried out. In brief, 50 lL of
each supernatant was pipetted into a 96-well plate, kept
on ice, and mixed with 100 lL of a phenol red washing
solution containing 140 mmol/L NaCl, 10 mmol/L potas-
sium phosphate buffer (pH 7.0), 5.5 mmol/L dextrose,
0.1 g/L phenol red, 8.5 U/mL horseradish peroxidase,
and 100 ng/mL phorbol myrisate acetate. Incubation was
carried out at 37◦C for 45, 90, and 120 minutes and ter-
minated by addition of 10 lL of 1 mol/L NaOH. Color
reading was done in an enzyme-linked immunosorbent
assay (ELISA) microplate reader at 620 nm. Values are
plotted against a standard curve generated from known
concentrations of H2O2. Results are expressed in arbi-
trary units and experiments repeated four times each in
triplicate.
Immunostaining for MnSOD and NADPH oxidase
(Gp91phox antibody)
HTrMCs grown on chamber slides were incubated
with control, morphine (10−6 mol/L), or morphine +
saquinavir (10 lmol/L) for 24 hours. At the end of the
incubation period, cells were fixed with 4%
paraformaldehyde followed by quenching of endogenous
peroxidases (0.03% H2O2 in methanol for 30 minutes).
Cells were preincubated in sheep anti-MnSOD (1:500 di-
lution) or mouse anti-Gp91phox antibody (1:100 dilution)
overnight at 4◦C followed by incubation with 1% rabbit
biotinylated antisheep IgG or 1% goat biotinylated anti-
mouse IgG and visualized by reaction with avidin-biotin
peroxidase (Vectastain Elite ABC kit) (Vector Labs,
Burlingame, CA, USA). The cells were then incubated
with diaminobenzidine tetrahydrochloride (Sigma
Chemical Co.) for 7 minutes at room temperature.
Protein extraction and Western blotting
for expression of HO-1
To determine the effect of morphine and hemin on
HO-1 expression by HTrMCs, equal numbers of HTrMCs
were incubated in media containing either vehicle, or
hemin for 16 hours followed by treatment with mor-
phine for 16 hours. At the end of the incubation period,
cells were washed and protein extraction and blotting
were performed as described previously [31]. The blots
were treated with 0.5% bovine serum albumin (BSA)
and 0.1% Tween-20 in 1 × PBS for 60 minutes at room
temperature and then incubated with the primary mon-
oclonal antibody to HO-1 (Stressgen, Victoria, Canada)
for 2 hours at 25◦C. A horseradish peroxidase-conjugated
secondary antibody was applied for 1 hour at room tem-
perature. The blots were then developed using a chemilu-
miniscence detection kit (ECL) (Amersham, Arlington
Heights, IL, USA) and exposed to Kodak X-OMAT AR
film (Rochester, NY, USA). The blots were stripped and
reprobed for b-actin. Quantitative densitometry was per-
formed on the identified band using a computer-based
measurement system.
Statistical analysis
Comparison of mesangial cell apoptosis between con-
trol and experimental conditions was carried out by an
unpaired Student t test. When more than two groups were
involved, inter-group comparisons were performed by
analysis of variance (ANOVA). A Newman-Keuls mul-
tiple range test was used to calculate a P value. Results
are represented as mean ± SEM.
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Fig. 1. Apoptosis in mesangial cells derived from controls (NTrMCs) and in mice transgenic for HIV-1 genes (HTrMCs). (A) Base line. Equal
numbers of NTrMCs and HTrMCs (10,000 cells/well) were incubated in media [RPMI + 1% fetal calf serum (FCS)] for 24 hours. At the end of the
incubation period, cells were stained with H-33342 and propidium iodide. Results (means ± SEM) are from four series of experiments, each carried
out in triplicate. (B) Dose response effects of protease inhibitors (PIs) on HTrMC apoptosis. Equal numbers of HTrMCs (10.000 cells/wall) were
incubated in media (RPMI + 1% FCS) containing either vehicle (C), variable concentrations of Indinavir or saquinavir (1, 5, and 10 lg/mL) for 24
hours. At the end of the incubation period, cells were assayed for apoptosis [terminal deoxynucleotidyl transferase-mediated uridine triphospphate
nick end labeling (TUNEL) method]. Results (means ± SEM) are from four sets of experiments, each carried out in triplicate. ∗P < 0.001 compared
with respective control and Indinavir/saquinavir, 1 lg/mL; ∗∗P < 0.001 compared with control and respective Indinavir/saquinavir, 1 and 5 lg/mL.
(C) Effect of saquinavir (SAQ) on morphine-induced HTrMC apoptosis. Equal numbers of HTrMCs were incubated in media (RPMI + 1% FCS)
containing either buffer (control), or morphine (10−8 and 10−6 mol/L) with or without saquinavir (10 lg/mL) for 24 hours. At the end of the
incubation period, cells were assayed for apoptosis by the TUNEL method. Results (means ± SEM) are from four series of experiments, each
carried out in triplicate. aP < 0.05 compared with control; bP < 0.001 compared with control and morphine, 10−8 mol/L; ∗P < 0.01 compared with
control; ∗∗P < 0.001 compared with morphine, 10−8 mol/L; ∗∗∗P < 0.001 compared with morphine, 10−6 mol/L. (D) Effect of saquinavir on DNA
fragmentation of HTrMCs. Equal numbers of (105 cells) HTrMCs were incubated in media (RPMI + 1% FCS) containing either vehicle (control),
morphine (10−6 mol/L), saquinavir (5 lg/mL) or saquinavir + morphine for 24 hours. At the end of the incubation, cells were harvested, and DNA
isolated and electrophoresed. Control and morphine treated cells are indicated by lanes 1 and 2, respectively. Saquinavir alone and saquinavir +
morphine treated cells are indicated by lanes 3 and 4, respectively. Molecular markers are shown in lane 5. Morphine-treated cells showed a ladder
pattern. Saquinavir partially attenuated this effect of morphine.
RESULTS
Evaluation of basal apoptosis in NTrMCs and HTrMCs
To determine basal apoptosis in mesangial cells,
NTrMCs and HTrMCs were incubated in media for
24 hours followed by an apoptosis assay. In parallel ex-
periments, cells were treated under similar conditions and
assayed by the TUNEL method. As shown in Figure 1A,
HtrMCs showed greater apoptosis when compared with
NTrMCs. Representative microphotographs of control
NTrMCs and HTrMCs are shown in Figure 2A and B.
Cells prepared for TUNEL assay also showed similar re-
sults (data not shown).
Effect of PI on HTrMC apoptosis
To evaluate the dose response effect of PIs on HTrMC
apoptosis, HTrMCs were treated with vehicle or variable
concentrations of Indinavir and saquinavir for 24 hours
followed by apoptosis assay (TUNEL method). The
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Fig. 2. Representative microphotographs of cells showing the oc-
currence of apoptosis under control/morphine-treated states and
expression of manganese superoxide dismutase (MnSOD)/Gp91phox.
Equal numbers of apoptosis in apoptosis in mesangial cells derived
from controls/mice transgenic for HIV-1 genes (NTrMCs/HTrMCs)
were incubated in media containing either buffer (control) or mor-
phine (10−6 mol/L) for 24 hours followed by staining with H-33342.
(A) Control NTrMCs. (B) Control HTrMCs. (C) HTrMC-treated
with morphine. Apoptosed cells show bright fluorescence (arrows)
(magnification ×200). Equal numbers of HTrMCs were incubated in
media containing buffer (control), morphine (10−6 mol/L), or mor-
phine + saquinavir (10 lg/mL) for 24 hours followed by immuno-
histochemical staining for MnSOD/Gp91phox (magnification ×150).
Control cells showed minimal staining for MnSOD (D) and Gp91phox
(G). Morphine-treated cells showed enhanced staining for MnSOD
(E) and Gp91phox (H); staining was more apparent in cells with con-
densed nuclei (undergoing apoptosis). Saquinavir + morphine-treated
cells show attenuated staining for MnSOD (F) and Gp91phox (I).
results are shown in Figure 1B. Both Indinavir and
Saquinavir inhibited HTrMC apoptosis in a dose-
dependent manner.
To confirm this effect of saquinavir, HTrMCs were
treated with vehicle or morphine in the presence or ab-
sence of saquinavir for 24 hours followed by a DNA
fragmentation assay. As shown, in Figure 1D, HTrMCs
showed DNA fragmentation in the form of a ladder pat-
tern. However, saquinavir partially inhibited the DNA
fragmentation of HTrMCs.
Effect of saquinavir on morphine-induced
HTrMC apoptosis
To determine the effect of saquinavir on morphine-
induced HTrMC apoptosis, HTrMCs were treated with
vehicle or morphine (10−8 and 10−6 mol/L) with or with-
out saquinavir for 24 hours followed by evaluation of
apoptosis. Results are shown in Figure 1C. Morphine pro-
moted HTrMC apoptosis. Saquinavir inhibited this ef-
fect of morphine. Representative microphotographs of
morphine-treated HTrMCs are shown in Figure 2C.
Effect of free radical scavengers on morphine-induced
mesangial cell injury
To determine the effect of free radical scavengers such
as SOD and catalase on morphine-increased NTrMC in-
jury, NTrMCs were treated with buffer, SOD, or catalase
with or without morphine for 24 hours followed by eval-
uation of cell injury (apoptosis and necrosis). Morphine
promoted (P < 0.001) apoptosis of NTrMCs (Fig. 3A).
This effect of morphine was attenuated by both SOD and
catalase. These findings suggest that morphine-induced
NTrMC apoptosis is mediated through the generation of
superoxide and H2O2.
To evaluate whether the same mechanism is playing a
role in morphine-induced HTrMC injury, we repeated the
experiment above using HTrMCs. As shown in Figure 3B,
morphine promoted (P < 0.001) HTrMC apoptosis. In
addition, morphine enhanced the necrosis of HTrMCs.
Nevertheless, these effects of morphine were inhibited
by SOD as well as by catalase.
Effect of antioxidants on apoptosis in NTrMCs
and HTrMCs
To confirm the role of oxidative stress in morphine-
induced NTrMC injury, NTrMCs were treated with
buffer, DPI, ascorbic acid, or NAC (50 lmol/L) with or
without morphine for 24 hours followed by an apop-
tosis assay. As shown, in Figure 3C, DPI, NAC, and
ascorbic acid (AA) inhibited morphine-induced NTrMC
apoptosis.
To study whether antioxidants can also prevent
morphine-induced HTrMC apoptosis, HTrMCs were
treated with antioxidants (as mentioned above) in the
presence or absence of morphine followed by mor-
phologic assay for apoptosis and necrosis. Morphine
promoted apoptosis of HTrMCs (Fig. 3D). Similarly, mor-
phine also promoted the necrosis of HTrMCs. Antioxi-
dants prevented these effects of morphine.
Effect of HO activity modulation on morphine-induced
HTrMC apoptosis
To determine the effect of HO activity modulation
on morphine-induced HTrMC apoptosis, HTrMCs were
treated with either buffer, hemin (an inducer of HO-1),
or tin protoporphyrin (an inhibitor of HO activity) for 6
hours followed by treatment with morphine for 18 hours.
Subsequently, cells were assayed for occurrence of apop-
tosis and necrosis. As shown in Figure 4A, morphine
promoted (P < 0.001) HTrMC apoptosis. This effect of
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Fig. 3. Effect of free radical scavengers and antioxidants on morphine-induced injury in mesangial cells derived from controls (NTrMC) and
mice transgenic for HIV-1 genes (HTrMCs). (A) Free radical scavengers. Equal numbers of NTrMCs (10,000 cells/well) were incubated in media
containing either buffer (control), superoxide dismutase (SOD) (50 lg/mL), or catalase (CAT) (2000 U/mL) with or without morphine (Mor) (10−6
mol/L) for 24 hours. At the end of the incubation, cells were stained with H-33342 and propidium iodide. Percentage of live, apoptotic, and necrotic
cells was recorded. Results (means ± SEM) are from four series of experiments, each carried out in triplicate. ∗P < 0.001 compared with other
variables. (B) Effect of SOD and catalase on morphine-induced HTrMC apoptosis. Equal numbers of HTrMCs were treated with either buffer
(control), SOD (50 lg/mL), or CAT (2000 U/mL) with or without morphine (Mor) (10−6 mol/L) for 24 hours followed by evaluation of cells for
apoptosis and necrosis. Results (means ± SEM) are from four sets of experiments, each carried out in triplicate. ∗P < 0.001 compared with other
variables inducing apoptosis; ∗∗P < 0.001 compared with other variables inducing necrosis. (C) Effect of antioxidants on morphine-induced NTrMC
injury. Equal numbers of NTrMCs (10,000 cells/well) were incubated in media containing buffer (control), diphenyleneiodonium chloride (DPI)
(10 lmol/L), ascorbic acid (AA) (100 lmol/L), or N-acetyl L-cysteine (NAC) (50 lmol/L) with or without morphine (Mor) (10−6 mol/L) for 24
hours. At the end of the incubation period, cells were stained with H-33342 and propidium iodide. Percentage of apoptotic and necrotic cells was
recorded. Results (means ± SEM) are from four series of experiments, each carried out in triplicate. ∗P < 0.001 compared with other variables. (D)
Effect of antioxidants on morphine-induced HTrMC injury. Equal numbers of HTrMCs were incubated in media containing buffer (control), DPI
(10 lmol/L), AA (100 lmol/L), or NAC (50 lmol/L) with or without morphine (Mor) (10−6 mol/L) for 24 hours. Subsequently, cells were assayed
for apoptosis and necrosis. Results (means ± SEM) are from four series of experiments, each carried out in triplicate. ∗P < 0.001 compared with
other variables inducing apoptosis; ∗∗P < 0.001 compared with other variables inducing necrosis.
morphine was further enhanced (P < 0.001) by hemin.
On the other hand, tin protoporphyrin partially inhibited
morphine-induced apoptosis.
Effect of morphine and hemin on HO-1 expression
by HTrMCs
To evaluate the effect of morphine and hemin on HO-1
expression by HTrMCs, cells were treated with buffer,
morphine (10−6 mol/L), hemin (5 lmol/L), or morphine
+ hemin (cells were preincubated with hemin for 16 hour
prior to addition of morphine). Subsequently, Western
blots were prepared and probed for HO-1 and actin.
As shown in Figure 4B, morphine promoted HO-1 ex-
pression by HTrMCs when compared with buffer-treated
cells. Hemin alone as well as in combination of mor-
phine generated enormous amount of HO-1 (seven-fold
greater) when compared with control cells.
Production of superoxide by NTrMCs and HTrMCs
To determine the production of superoxide by mesan-
gial cells under basal and morphine stimulated states,
NTrMCs and HTrMCs were treated with vehicle or mor-
phine for variable time periods followed by an assay
for superoxide in supernatants. Morphine stimulated the
production of superoxide by NTrMCs and HTrMCs from
30 minutes onward. This effect of morphine peaked at
60 minutes. The 60-minute results are shown in
Figure 5A. HTrMCs produced greater (P < 0.001) su-
peroxide under control and morphine stimulated states
when compared with NTrMCs. Nevertheless, morphine
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Fig. 4. Effect of HO activity in mesangial cells derived from mice
transgenic for HIV-1 genes (HTrMC). (A) Heme oxygenase (HO) ac-
tivity modulation on morphine-induced apoptosis. Equal numbers of
HTrMCs were incubated in media containing either buffer (C), hemin
(H) (5 lmol/L), an inducer of HO-1, or tin protoporphyrin (T) (50
lmol/L), an inhibitor of HO-activity for 16 hours followed by reincuba-
tion in media containing either buffer or morphine (Mor) (10−8 mol/L)
for 18 hours. At the end of the incubation period, cells were stained
with H-33342 and propidium iodide. Results (means ± SEM) are from
three sets of experiments, each carried out in triplicate. ∗P < 0.001 com-
pared with control; ∗∗P < 0.001 compared with morphine; ∗∗∗P < 0.05
compared with morphine. (B) Effect of morphine and hemin on HO-1
expression by HTrMCs. Equal numbers of HTrMCs were incubated in
media containing either buffer (control), morphine (10−6 mol/L), hemin
(5 lmol/L), or morphine + hemin (cells were preincubated with hemin
for 16 hours prior to addition of morphine) for 16 hours. At the end
of the incubation, cells were harvested, proteins extracted, and West-
ern blots prepared and probed for HO-1 and actin. The upper panel
shows HO-1 expression by HTrMCs under buffer-, morphine-, hemin-
and morphine + hemin-treated conditions. The lower panel shows actin
content under similar conditions.
stimulated (P < 0.001) the production of superoxide in
both NTrMC and HTrMCs. (Fig. 5A).
To determine the effect of DPI and SOD on HTrMCs
under basal and morphine-stimulated states, HTrMCs
were treated with serum-free media containing either ve-
hicle, DPI, or SOD with or without morphine for 120 min-
utes followed by a superoxide assay of the supernatants.
As shown in Figure 5B, morphine stimulated (P < 0.001)
superoxide production by HTrMCs. Both DPI and SOD
inhibited (P < 0.001) this effect of morphine.
To determine the effect of saquinavir on the produc-
tion of superoxide by HTrMCs, HTrMCs were treated
with vehicle or variable concentrations of saquinavir
in the presence or absence of morphine for 120 min-
utes followed by a superoxide assay of the supernatants.
As shown in Figure 5C, saquinavir in 5 and 10 lg/mL
concentrations inhibited the production of superoxide.
Morphine promoted (P < 0.001) the production of super-
oxide by HTrMCs; nevertheless this effect of morphine
was attenuated by saquinavir.
H2O2 production by NTrMCs and HTrMCs
To determine the production of H2O2 by mesangial
cells, NTrMCs and HTrMCs were treated with either vehi-
cle or catalase with or without morphine for 120 minutes
followed by assay of supernatants for H2O2. As shown in
Figure 5D, HTrMCs produced greater (P < 0.001) H2O2
under basal and morphine-stimulated states when com-
pared with NTrMCs. Morphine stimulated H2O2 produc-
tion of both NTrMCs and HTrMCs. Catalase attenuated
this effect of morphine in both types of cells.
Effect of PI on morphine-stimulated MnSOD
and NADPH oxidase activation
To determine the effect of PIs on morphine-stimulated
SOD and NADPH oxidase activation, HTrMCs were
treated with morphine with or without saquinavir for
24 hours followed by immunohistochemical staining for
MnSOD and Gp91phox. Cumulative data are shown in
Table 1. Representative microphotographs are shown in
Figure 2D to I. Morphine treated cells showed greater
staining for MnSOD when compared with control cells
(Fig. 2D). However, this effect of morphine was attenu-
ated by saquinavir (Fig. 2F).
As shown in Figure 2H, morphine-treated HTrMCs
also showed greater staining for Gp91phox when com-
pared with untreated cells (Fig. 2G). Nevertheless, this
effect of morphine was inhibited by saquinavir (Fig. 2I).
Effect of saquinavir on other known models of reactive
oxygen species–induced mesangial cell injury
To study whether the effect of saquinavir has a re-
lationship with reactive oxygen species generation by
mesangial cells, we evaluated the effect of saquinavir on
various models of reactive oxygen species generation.
HTrMCs/NTrMCs were treated with HIV transactivator,
Tat, serum-free media or morphine in the presence or ab-
sence of saquinavir for 24 hours followed by an apoptosis
assay. As shown in Figure 6, Tat, morphine, and serum-
free media triggered variable degrees of apoptosis in both
HTrMCs and NTrMCs. However, saquinavir partially in-
hibited apoptosis in all these models of reactive oxygen
species–induced cellular apoptosis.
Effect of saquinavir on nitric oxide–induced
mesangial cell injury
To determine the effect of saquinavir on nitric oxide–
mediated cellular injury, NTrMCs/HTrMCs were treated
with variable concentrations of sodium nitroprusside in
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Fig. 5. Effect of morphine on superoxide generation by mesangial cells derived from controls (NTrMCs) and mice transgenic for HIV-1 genes
(HTrMCs) (at 60 minutes). (A) Equal numbers of NTrMCs and HTrMCs (105 cells/well) were incubated in media (serum-free) containing either
vehicle (control) or morphine (10−6 mol/L) for up to 120 minutes. Supernatants were collected at various time periods and assayed for superoxide.
We have shown the results of the 60 minutes of incubation (means ± SEM) from three sets of experiments, each carried out in triplicate. ∗P <
0.001 compared with respective control; ∗∗P < 0.001 compared with NTrMC control; ∗∗∗P < 0.001 compared with morphine-treated NTrMCs. (B)
Effect of diphenyleneiodonium chloride (DPI) and superoxide dismutase (SOD) on morphine-induced superoxide generation by HTrMCs (at 60
minutes). Equal numbers of HTrMCs (105 cells/well) were incubated in serum-free media containing either vehicle (control), DPI (10 lmol/L),
or SOD (50 lg/mL) with or without morphine (Mor) (10−6 mol/L) for 120 minutes. Supernatants were collected at different time periods and
assayed for superoxide. Results (means ± SEM) are from three sets of experiments. ∗P < 0.001 compared with all other variables; ∗∗P < 0.001
compared with control. (C) Effect of saquinavir (SAQ) on superoxide production by HTrMCs (at 60 minutes). Equal numbers of HTrMCs (105
cells/well) were incubated in serum-free media containing either vehicle (control), variable concentrations of SAQ (1, 5, and 10 lg/mL), morphine
(Mor) (10−6 mol/L), or SAQ (10 lg/mL) + Mor for 120 minutes. Supernatants were collected at different time periods and assayed for superoxide.
Results (means ± SEM) are from three sets of experiments. ∗P < 0.001 compared with control and SAQ (1 lg/mL); ∗∗P < 0.001 compared with
control; ∗∗∗P < 0.001 compared with morphine treated cells. (D) Effect of catalase on H2O2 production by NTrMC and HTrMCs (at 60 minutes).
Equal numbers of NTrMCs and HTrMCs (105 cells/well) were incubated in media (serum-free) containing either vehicle (control), or catalase
(CAT) (2000 U/mL) with or without morphine (10−6 mol/L) for 120 minutes. Supernatants were collected at different time periods and assayed
for H2O2. Results (means ± SEM) are from three sets of experiments, each carried out in triplicate. ∗P < 0.001 compared with control NTrMCs;∗∗P < 0.001 compared with other NTrMC variables; ∗∗∗P < 0.001 compared with other HTrMC variables.
the presence of saquinavir (5 lg/mL) followed by apop-
tosis assay. As shown in Figure 7, sodium nitroprus-
side triggered apoptosis in both NTrMCs and HTrMCs.
Saquinavir did not modulate this effect of sodium nitro-
prusside. These findings suggest that saquinavir does not
modulate nitric oxide–induced mesangial cell apoptosis.
DISCUSSION
The present study demonstrates that the accelerated
rate of apoptosis in HTrMCs is associated with increased
generation of reactive oxygen species. In addition, antiox-
idants as well as free radical scavengers inhibit HTrMC
apoptosis and necrosis. Morphine triggers apoptosis of
NTrMCs as well as HTrMCs; both antioxidants and free
radical scavengers attenuated this proapoptotic effect
of morphine. PIs such as saquinavir and Indinavir in-
hibited HTrMC apoptosis in a dose-dependent manner.
Saquinavir attenuated HTrMC apoptosis both under
basal and morphine-stimulated states. Saquinavir also in-
hibited superoxide production by HTrMCs under basal
as well as morphine-stimulated states. Since DPI, an
inhibitor of NADPH oxidase, prevented morphine-
induced apoptosis and morphine enhanced expression of
Gp91phox by HTrMCs, it appears that morphine-induced
oxidative stress may be mediated through NADPH
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Table 1. Effect of saquinavir (SAQ) on morphine-induced apoptosis
in mesangial cells derived from mice transgenic for HIV-1 genes
(HTrMC) labeling for superoxide dismutase (MnSOD) and gp91phox
Control Morphine SAQ + morphine
% MnSOD +ve cells 17.6 ± 1.5 37.5 ± 2.5a 26.6 ± 2.0b
% gp91phox +ve cells 37.5 ± 3.2 65.2 ± 4.7c 43.3 ± 2.1b
Equal numbers of HTrMCs were incubated in media containing buffer
(control), morphine (10−6 mol/L), or morphine + SAQ (10 lg/mL) for 24 hours
followed by immunohistochemical staining for MnSOD/Gp91phox. Percentage of
labeled cells was counted in eight random fields for calculating means. Results
(means ± SEM) are from four sets of experiments.
aP < 0.001 compared with respective control; bP < 0.05 compared with
respective morphine; cP < 0.01 compared with respective control.
oxidase activation. These findings suggest that an accel-
erated rate of apoptosis in HTrMCs may be mediated
through the generation of reactive oxygen species. PIs
seem to inhibit HTrMC apoptosis by decreasing the sever-
ity of oxidative stress.
PIs modulate cell function in multiple ways, including
apoptosis, antigen presentation, lipoprotein metabolism,
cytochrome P450 activity, adipocyte differentiation, in-
teraction with cellular aspartyl proteases, inhibition of
proteosome activity, and blocking of cathepsin D [33–36].
PIs block spontaneous apoptosis as well as apoptosis in-
duced by various stimuli [33, 35]. Wan and De Petrillo [36]
demonstrated that ritonavir (Norvir) prevented neuronal
apoptosis via attenuation of oxidative stress. Wiechold
et al [20] reported that PI might inhibit apoptosis of pe-
ripheral blood monocytes in patients with HIV infec-
tion by lowering monocyte expression of caspase-1 and
caspase-3 activity. Similarly, Sloand et al [34] report that
PI attenuates CD4+ T cell apoptosis by lowering the ex-
pression of caspase-1. Phenix et al [18] demonstrated that
PI inhibits the potential loss of the mitochondrial trans-
membrane and subsequent release of apoptotic media-
tors. In the present study, saquinavir inhibited apoptosis
of mesangial cells under basal as well as morphine stimu-
lated states. This effect of saquinavir was associated with
a decrease in the production of superoxide. Thus, it ap-
pears that saquinavir may be attenuating mesangial cell
apoptosis by attenuating the degree of oxidative stress
under both basal and morphine stimulated states.
HO-1 has been considered a biologic marker of oxida-
tive stress [37]. However, preinduction of HO-1 has been
shown to attenuate the severity of inflammation in var-
ious animal experimental models [38–40]. In a previous
report, pretreatment of mesangial cells with hemin, an in-
ducer of HO-1, protected against the proapoptotic effect
of angiotensin II; conversely, inhibition of HO activity of
mesangial cells by zinc protoporphyrin, exacerbated an-
giotensin II–induced mesangial cell apoptosis [41]. How-
ever, in the present study, pretreatment of HTrMCs with
hemin exacerbated morphine-induced HTrMC apopto-
sis; whereas, tin protoporphyrin partially inhibited the
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Fig. 6. Effect of saquinavir (SAQ) on reactive oxygen species–induced
apoptosis in mesangial cells derived from controls (NTrMCs) and mice
transgenic for HIV-1 genes (HTrMCs). (A) Equal numbers of NTrMCs
were incubated in serum-free media containing either buffer alone
(serum starved) (SS), buffer + serum (control), Tat (0.01 lg/mL) +
serum, morphine (Mor) (10−6 mol/L) + serum with or without SAQ (5
lg/mL) for 24 hours followed by an apoptosis assay. Results (means ±
SEM) are from three sets of experiments, each carried out in tripli-
cate. ∗P < 0.001 compared with control and Mor + SAQ; ∗∗P < 0.01
compared with control; ∗∗∗P < 0.01 compared with Tat alone; ∗∗∗∗P <
0.05 compared with SS alone. (B) Equal numbers of HTrMCs were
incubated in serum-free media containing either buffer alone (serum
starved) (SS), buffer + serum (control), Tat (0.01 lg/mL) + serum, mor-
phine (Mor) (10−6 mol/L) + serum with or without SAQ (5 lg/mL) for
24 hours followed by an apoptosis assay. Results (means ± SEM) are
from three sets of experiments, each carried out in triplicate. ∗P < 0.001
compared with control; ∗∗P < 0.001 compared with control and SAQ +
SS; ∗∗∗P < 0.05 compared with control; aP < 0.001 compared with Tat
alone; bP < 0.001 compared with morphine alone.
morphine-induced HTrMC apoptosis. These findings sug-
gest that HO activity may accelerate HTrMC injury.
Other investigators have also suggested that HO-1 may
not be cytoprotective in all instances [42, 43]. Each of
the products of HO-1 expression may be toxic in some
instances. According to the present study, the enhance-
ment of HO activity may not always be beneficial in an
accelerated state of oxidative stress. Perhaps heightened
ongoing oxidation may already be inducing significant
HO-1 production to contain the oxidative stress. Thus,
further exacerbation of HO-1 production by hemin may
lead to the accumulation of HO-1 products to the toxic
level. It has been suggested that a low level (less than five-
fold) of HO-1 induction is beneficial; on the other hand,
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by an apoptosis assay. Results (means ± SEM)
are from three sets of experiments. ∗P <0.01
compared with respective control; ∗∗P < 0.001
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(10 mmol/L).
too much of HO-1 expression may be detrimental [44].
In the present study, morphine enhanced HO-1 expres-
sion by HTrMCs. However, hemin-treated cells showed
seven-fold greater expression of HO-1 when compared
with control cells. These findings are consistent with the
observations of other authors [44].
Activation of NADPH oxidase is an important source
for the generation of superoxide. NADH and NADPH
oxidase are present in mesangial cells, endothelial cells,
fibroblasts, vascular smooth muscle cells, and phagocytic
mononuclear cells [45, 46]. The increased cellular activ-
ity of NADH and NADPH oxidase enhances the produc-
tion of reactive oxygen species by multiple pathways, in-
cluding the increased activation of xanthine oxidase, the
autooxidation of NADH, and the inactivation of SOD
[45, 46]. Since DPI, an inhibitor of NADPH oxidase
attenuated HTrMC apoptosis under both basal and
morphine-stimulated states, it appears that these cells
may be generating superoxide through the activation
of NADPH oxidase. This effect of morphine was fur-
ther confirmed by morphine-triggered expression of
Gp91phox by HTrMCs. Interestingly, morphine stimulated
HTrMC’s production of MnSOD. This effect of morphine
may be either direct or related to the enhanced genera-
tion of superoxide. Nevertheless, this effect of morphine
was inhibited by saquinavir.
In humans as well as in experimental models of FGS,
expansion of the mesangium precedes the development
of FGS [47, 48]. The expanded mesangium is comprised
of a large number of mesangial cells and an increased
amount of matrix. However, in the latter course of the dis-
ease, there is an abundance of matrix and a limited num-
ber of mesangial cells [49–51]. Interestingly, mesangial
cell hyperplasia is the most common reported glomeru-
lar lesion in patients with HIV infection [2, 5]. Since this
glomerular lesion may be the initiating event for the de-
velopment of FGS, the antiapoptotic effect of PI may not
help to contain the initiating event. However, in the latter
course of FGS, PI may slow down the loss of mesangial
cells in the progressive renal lesions. Analysis of renal
biopsy specimens in patients on HARRT therapy may
provide further insight into this aspect. The present study
suggests that PIs may modulate the progression of renal
lesions independent of their effects on the viral load.
In the present study, PIs attenuated cellular injury in
reactive oxygen species–induced stress only. Thus, it ap-
pears that PIs may either be neutralizing the reactive oxy-
gen species–induced oxidative stress or decreasing the
generation of reactive oxygen species. The later mecha-
nism seems to be playing a role because PIs inhibited the
production of reactive oxygen species by mesangial cells.
Since saquinavir inhibited morphine-induced apoptosis
both in HTrMCs and NTrMCs, this effect of saquinavir is
independent of the presence of HIV-1 gene.
We conclude that accelerated apoptosis in HTrMCs is
mediated through oxidative stress. Morphine exacerbates
HTrMC apoptosis by worsening oxidative stress. PIs in-
hibit apoptosis of HTrMCs by attenuating the severity of
oxidative stress.
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